Vaccine Packs Rapidly Expand Biologics Adoption
Biologics developers increasingly specify vaccine and biologics insulation packs previously limited to a handful of pilot recyclability programs, applying documented thermal engineering across an expanding list of mid-size regional developers as compliance-risk expectations increasingly make verified insulation performance a measurable procurement attribute rather than a manageable packaging detail. This shift is creating substantial new demand beyond the category's traditional perishable-food base, giving vaccine-capable converters a genuine growth avenue tied to specification-driven adoption rather than pure basic-insulation volume growth. Converters with established brand relationships are capturing disproportionate share of this expanding demand worldwide.
Market Impact: Sustains 27% of category volume








